Castle Biosciences Inc
CSTL
Get informed when a big investor buys or sells
+ FollowMarket Cap$640.57M
Close$
$33.86
53.1% upside
Current Fair Value
53.1% upsideUndervalued by 53.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $640.57 Million |
|---|---|
| Enterprise Value | $613.53 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.83 |
| Beta | 1.02 |
| Outstanding Shares | 29,889,000 |
Return
| Return on Equity | -2.78% |
|---|---|
| Return on Assets | -2.34% |
| Return on Invested Capital | -6.33% |
Valuation & Multiples
| P/E Ratio | -49.17 |
|---|---|
| PEG | 112.22 |
| Price to Sales | 2.01 |
| Price to Book Ratio | 1.47 |
| Enterprise Value to Revenue | 1.8 |
| Enterprise Value to EBIT | -19.43 |
| Enterprise Value to Net Income | -48 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.08 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 11, 2026
EPS Estimate
$-0.49
Average shareholder expectationRevenue Estimate
$79.28 M
Average shareholder expectationNext Earnings Call
Expected Date
August 3, 2026
EPS Estimate
$-0.38
Average shareholder expectationRevenue Estimate
$86.26 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.1935▲ 19.35% |
|---|---|
| Total Calls | 64,600▼ 7.85% |
| Total Puts | 12,500▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 94.13%▼ 14.90% |
|---|---|
| Total Invested | $677.76M▼ 36.18% |
| Investors Holding | 190▼ 8.00% |
ESG Score
No data